The truth is clear: GSK concealed Paxil risks and, like other pharma companies, promoted SSRIs off-label — including to kids, despite no FDA approval.

Now a medical journal is considering a retraction of the 2001 “study” it published that falsely said Paxil was safe and effective for adolescents. The data were manipulated, and serious side effects—like suicidal thoughts—were buried.

We can’t change the past, but we can protect the future. Please share MISSD’s resources to help others recognize the warning signs of akathisia and prevent avoidable harm.

The full STAT article is subscription-only, but this knowledge is now (belatedly) well established. See: https://www.statnews.com/pharmalot/2025/08/25/antidepressant-paxil-gsk-medical-journal-children-adolescents-depression-ghostwriting-retraction/.